In the present study, we investigated the sensitivity of integrated analysis of multiomics datasets to identify shared downstream pathways and differences in signaling in HGGs driven by two different glioma-associated RTK mutations in the same p53-null primary astrocyte population. This evidence concerns the gene TP53 and central nervous system cancer.